Findings

What do systematic reviews say?

63 questions · 69 findings · 8 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 20 · 29%GRADE not reported 1 · 1.4%Very low 11 · 15.9%Low 19 · 27.5%Moderate 14 · 20.3%High 4 · 5.8%

IVIg vs acetylsalicylic acid (ASA)

Need for extra treatment · people undergoing initial treatment for KD

Primary treatment with intravenous immunoglobulin (IVIG) showed no clear difference in need for additional treatment (up to 30 or 60 days) compared with acetylsalicylic acid (ASA) (low certainty).

1 finding from 1 review

Intravenous immunoglobulin for the treatment of Kawasaki disease 2023 · Cochrane Headline outcomes only
OR 0.27 [0.05, 1.57]
3 studies · 272 participants
Low

IVIg vs acetylsalicylic acid (ASA)

Length of hospital stay · people undergoing initial treatment for KD

The review found no eligible studies for this question.

1 finding from 1 review

Intravenous immunoglobulin for the treatment of Kawasaki disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

IVIg vs acetylsalicylic acid (ASA)

Mortality (all‐cause) · people undergoing initial treatment for KD

1 finding from 1 review

Intravenous immunoglobulin for the treatment of Kawasaki disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low